Monday, 13 October 2014

Lot of Alzheimer’s Research is Happening in Roskamp



A lot of people have degenerative memory and it gets worsened with age. As people grow old, they start forgetting things and even the basic and daily routine things become difficult for them. While some people have dementia, others suffer from Alzheimer’s. There is quite a lot of Alzheimer’s Research happening in Roskamp. This research tries to find causes and treatments for the disease.


Michael Mullan


What happens in Roskamp?

The Roskamp Institute is a world famous institute and is focused on understanding the causes of the disease and tries to find cures for the neuro-degenerative and neuro-psychiatric addictions and disorders. The institute makes use of various scientific methods for understanding the causes and therapies for these kinds of disorders. The main emphasis is laid on Alzheimer’s.

Based in Sarasota, this institute has a full team of technicians and scientists who are experienced in various disciplines. The laboratory has the state-of-the-art facilities and equipment for research work. And, the quality of this research is excellent as they believe that better science leads to real discovery.

What does the research work involve?

The entire teams of scientists in Roskamp have produced a complete library of sugars named Heparin Sulfate. These proteins are known for controlling the proteins in brains which causes memory loss. As per this research, it has been found out that Heparin sup hates can be efficiently produced chemically in the lab. These proteins are known to block the enzymes in the brains which creates smaller proteins. These proteins that are created by the enzymes are the amyloid proteins. The Amyloid proteins work as the building blocks for creating plaque which causes memory loss as Alzheimer’s progresses. As per Professor Jerry Turnbull, the enzymes that are targeted with chemically produced sugars is the BACE. This is the enzyme which is responsible for creation of the Amyloid Proteins. As per BACE, the difficult enzymes are isolated and blocked in spite of various efforts by the drug companies. And, the ability of mass-producing the heparin sulfates allows the scientists to further and continue the research on enzymes. More research work will be done using this new chemical approach. And, this research will test the heparin that works effectively towards blocking the enzymes and gives out the least side effects. The lab techniques which allow heparin production in mass will allow more continuous research and the new medications will target towards treating and slowing down of degenerations and disorders.

Who heads the research work in Roskamp?

This institute is headed by Michael Mullan, who is a bio-medical researcher. His research is quite popular amongst the bio-medical community. Dr. Mullan’s research has resulted in finding out the most popular Swiss Mutation. The transgenic animals for the Alzheimer’s makes use of Swiss Mutation. Dr. Mullan is the director of the institute in Roskamp, whose research work is famous for traumatic brain research, Alzheimer’s and other neuron-psychiatric disorders.

With the help of this new research, the Alzheimer’s disorder can be easily treated. And, all those patients and families who have lost hope can find a ray of hope now.

For More Details Visit Here: -- Michael Mullan

Monday, 15 September 2014

The Making Of The Roskamp Institute Under The Guidance Of Dr. Michael Mullan

Getting to know about the stories of great personalities is really an asset to one’s knowledge. These are real inspiring stories which let you learn that success never comes to those who always just dream for it; it only comes to those who work in the direction of turning those dreams into reality. 

One such great personality who had fervour to do something extraordinary is Michael Mullan. He is the greatest scientists that the world has ever had. He had the zeal to discover remedies for brain disorders and he dedicated his life into research of these diseases. Even today, he does not believe in taking rest and is still working towards developing better solutions for Alzheimer’s disease.


An Insight View of Michael Mullan’s Academic Career 
Dr. Michael Mullan completed his graduation as a medical practitioner. He started his first research work at the Institute of Psychiatry, London University. Here, he began his research in the field of molecular genetics. After this, he attained a Mental Health Foundation Research Fellowship at St. Mary’s Hospital Medical School to retrain in molecular genetics. 

He was senior author on several articles and research papers pertaining to the genetic disturbances which lead to the early onset of Alzheimer. He has served as a co-author for more than 200 research papers associated with the Alzheimer’s disease. He has also worked as a professor of Pathology, Neurology and Psychiatry. In the year 1992, he joined the University in Tampa and established the Roskamp Laboratories.

Inception of Roskamp Institute
In the year 1998, Michael Mullan established the famous Roskamp Institute. This institute has been set up to find better and effective treatments for the Alzheimer’s disease and other brain disorders. In the year 2003, this institute was relocated to a fully fledged research facility in Sarasota, Florida. He is currently operating as the President of the Roskamp Institute. He is also the CEO of the Archer Pharmaceuticals. This institute consists of more than 70 scientists, students, clinical and support staff pursuing advanced scientific understanding of neuropyschiatric diseases. 

This institute is funded through multifarious sources such as the National Institutes of Health, the Veteran’s Administration, the Alzheimer’s Association and the Department of Defence. This institute has also conducted a clinical trial of Alzheimer in Europe with a new and safe medicinal drug which shows greater and faster recovery in humans. Here, Dr. Mullan also discovered the beta-amyloid proteins and their association with the Alzheimer’s disease.

Contributions of Dr. Mullan towards Neuropsychiatric Disorders
Dr. Mullan is a well known biomedical researcher. Under his expert guidance, the institute of Roskamp is earning accolades from worldwide for its advanced research works in the spheres of Traumatic Brain Research, Gulf War Syndrome, Alzheimer’s disease and other neuropsychiatric disorders. 

Moreover, Dr. Mullan has also discovered certain new factors which are leading to this perilous disease. He has also described some really easy methods to prevent as well as cure this disease when detected at the early stages. His research work has also contributed immensely in identifying the well known Swiss Mutation. 

It can be deduced from above that Michael Mullan Roskamp is a man of firm-determination and finds the purpose of his life in serving the mankind in the best way he can.

Monday, 11 August 2014

MICHAEL MULLAN AND HIS ALZHEIMER’S RESEARCH AT FLORIDA



All about the Great Researcher

Biomedical researcher Michael Mullan has conducted Alzheimer’s disease which was based on the identification of the Swedish Mutation which is present in the familial form. This person is trained in England as a physician and received his medical degree in 1995 and PhD in molecular genetics from London University. Currently he is working as a CEO and the president of the Roskamp Institute. He has published more than 200 papers.




He had conducted the important medical research in neurodegenerative disorders. He is a very experienced person and is also imparting knowledge on the subject dementia. He is working in research centers and medical institutions too.

Fighting Alzheimer’s Disease

It was a very great study by him at Roskamp Institute at Sarasota Florida in which he discovered that that all the disorders which are genetic are found to be in amyloidal genes. The whole of this research was basically based on the Amyloid and now is categorized as a very important part of the Alzheimer’s disease. It is also found that this disease is commonly found at the ages of 50 to 70. All the studies which were conducted followed by a result that the small protein amyloid when accumulates can contribute to the series of things which can lead to cognitive declination and degeneration.

The research was going-on on mice which had the errors in it like a human who is on the early stage of the disorder called Alzheimer. This study on the mice  has gave the researchers an idea about how a small protein called amyloid can cause disorder  and can lead to the death of neurons. Many of the pharmaceutical labs and academic labs have this kind of mice. So they used to test many such drugs on the mice which can prevent them from this disease. Just to give a solution to this problem, many researches were conducted. This disease actually came from a family of a woman Carol Jennings from England. Her family had this genetic problem in which fifty percent that is half of the off springs who used to take birth in their family were having this disease at an early stage. And then she started for the search of the people who were interested to carry on the research on Alzheimer’s disease. By doing this she not only helped her family but also helped the people who were suffering from this disease.

At all the positions on which Michael Mullan worked, he made efforts to research on the cure of neurodegenerative disorders for the long-term.
The Roskamp institute at which he worked was always working on the fact that they wanted to understand the causes and the perfect cures for neuropsychiatric and neurodegenerative disorders and the kind of addictions that happens due to that. This institute had utilized all the range of scientific and technological approaches, so that they can understand its causes and the kind of various therapies for curing this disorder with the emphasis laid on the Alzheimer’s disease.

For More Details Visit Here: -- Michael Mullan Roskamp

Tuesday, 15 July 2014

Scientist of Repute, Michael Mullan Gives Strength to Alzheimer’s Research



Scientific research work is more about involvement, in-depth knowledge and dedication. The desire to exceed in the present resources of knowledge leads people to earn a name that goes beyond selfish and eccentric goals. It is with such a dedication that Dr Michael Mullan has been working for more than 3 decades towards the understanding of neurodegenerative changes like Alzheimer’s as well as other brain dysfunctions. His extensive research in the field has not only been a subject of discussion to delve deep into the brain pathology of senile dementia patients, but also has assisted other scientists to unravel some other aspects of these diseases.




·         Life of Dr Mullan explicitly filled up with research and studies on neurosciences

While Dr Michael Mullan has been presently active in Sarasota in Florida, in the Roskamp Institute as the Chief Executive Officer, his journey began much earlier in London, where he started his career in medicine. From the very beginning of his studies, Michael Mullan has been keen about studying the brain functions. As a result of his interest, he got into Ph.D. and then received fellowships from London as well as other renowned institutes and universities in England and America in the capacity of a scientist par excellence. Most of these degrees were awarded to him for his striking work in psychiatry and neurodegenerative aspects of brain. But for the last few years, he has been deeply associated with Roskamp Institute in Florida, simultaneously also holding certain important posts in institutions involved in work of degeneration of brain.

·         Backing his research with publications becoming work of reference

To strengthen his reputation as a leading researcher in the field of neurosciences, Dr Mullan has published a lot of papers on psychiatric disease pathologies and in Alzheimer’s disease. His work relate to the deeper understandings of the brain functions, along with being path-breaking in the pathology of Alzheimer. All of this published works are strong references for many other scientists and his talks across the world have become the topics of discussion. These topics have been of benefit for many people, especially those belonging to scientific communities in general and to the field of Alzheimer’s in particular. Taking the lead of Dr Michael Mullan as a scientist and researcher, many others have added to his valuable studies, thereby helping mankind come a step closer towards alleviating the problems of Alzheimer’s.

·         Growing strength by strength to build up strong research base on Alzheimer

Over the last three to four decades of association with the research sector of medical science, Dr Mullan has garnered a lot of experience. This association has allowed him to be one of the recognised figures in the field of neurodegenerative research. His works are not only path-breaking, but also exemplary in the manner in which they stress upon various diagnostic and therapeutic implications. After having all the exposure towards such a field, he is carrying ahead the good work at Sarasota in Florida as a scientist and leading a group of dedicated scientific team in further research of Alzheimer’s disease. The vast ocean of knowledge and the information gathered by Dr Mullan has surely done a great deal of good towards research and therapy of Alzheimer.

For More Details Visit Here: -- Michael Mullan Florida